Literature DB >> 16317762

Purification and characterization of a novel mammalian endoribonuclease.

Kirk Bergstrom1, Joel C Urquhart, Alaeddin Tafech, Erin Doyle, Chow H Lee.   

Abstract

Endonuclease-mediated mRNA decay appears to be a common mode of mRNA degradation in mammalian cells, but yet only a few mRNA endonucleases have been described. Here, we report the existence of a second mammalian endonuclease that is capable of cleaving c-myc mRNA within the coding region in vitro. This study describes the partial purification and biochemical characterization of this enzyme. Five major proteins of approximately 10-35 kDa size co-purified with the endonuclease activity, a finding supported by gel filtration and glycerol gradient centrifugation analysis. The enzyme is an RNA-specific endonuclease that degrades single-stranded RNA, but not double-stranded RNA, DNA or DNA-RNA duplexes. It preferentially cleaves RNA in between the pyrimidine and purine dinucleotides UA, UG, and CA, at the coding region determinant (CRD) of c-myc RNA. The enzyme generates products with a 3'hydroxyl group, and it appears to be a protein-only endonuclease. It does not possess RNase A-like activity. The enzyme is capable of cleaving RNAs other than c-myc CRD RNA in vitro. It is Mg(2+)-independent and is resistant to EDTA. The endonuclease is inactivated at and above 70 degrees C. These properties distinguished the enzyme from other previously described vertebrate endonucleases. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16317762     DOI: 10.1002/jcb.20726

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  9 in total

Review 1.  Novel endoribonucleases as central players in various pathways of eukaryotic RNA metabolism.

Authors:  Rafal Tomecki; Andrzej Dziembowski
Journal:  RNA       Date:  2010-07-30       Impact factor: 4.942

2.  RNA-cleaving properties of human apurinic/apyrimidinic endonuclease 1 (APE1).

Authors:  Wan-Cheol Kim; Dustin King; Chow H Lee
Journal:  Int J Biochem Mol Biol       Date:  2010-03-10

3.  Control of c-myc mRNA stability by IGF2BP1-associated cytoplasmic RNPs.

Authors:  Doreen Weidensdorfer; Nadine Stöhr; Anne Baude; Marcell Lederer; Marcel Köhn; Angelika Schierhorn; Sabine Buchmeier; Elmar Wahle; Stefan Hüttelmaier
Journal:  RNA       Date:  2008-11-24       Impact factor: 4.942

4.  UU/UA dinucleotide frequency reduction in coding regions results in increased mRNA stability and protein expression.

Authors:  Maher Al-Saif; Khalid S A Khabar
Journal:  Mol Ther       Date:  2012-03-20       Impact factor: 11.454

5.  CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease.

Authors:  Dan Sparanese; Chow H Lee
Journal:  Nucleic Acids Res       Date:  2007-01-30       Impact factor: 16.971

Review 6.  Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases.

Authors:  Nadezhda Mironova; Valentin Vlassov
Journal:  Front Pharmacol       Date:  2019-09-13       Impact factor: 5.810

7.  Identification of Apurinic/apyrimidinic endonuclease 1 (APE1) as the endoribonuclease that cleaves c-myc mRNA.

Authors:  Tavish Barnes; Wan-Cheol Kim; Anil K Mantha; Sang-Eun Kim; Tadahide Izumi; Sankar Mitra; Chow H Lee
Journal:  Nucleic Acids Res       Date:  2009-04-28       Impact factor: 16.971

8.  Assessing specific oligonucleotides and small molecule antibiotics for the ability to inhibit the CRD-BP-CD44 RNA interaction.

Authors:  Dustin T King; Mark Barnes; Dana Thomsen; Chow H Lee
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

Review 9.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

Authors:  Jessica L Bell; Kristin Wächter; Britta Mühleck; Nikolaos Pazaitis; Marcel Köhn; Marcell Lederer; Stefan Hüttelmaier
Journal:  Cell Mol Life Sci       Date:  2012-10-16       Impact factor: 9.261

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.